The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1

BACKGROUND: The ability to distinguish hepatocellular carcinoma (HCC) from metastatic carcinoma (MC) involving the liver and cholangiocarcinoma (CC) by immunohistochemistry has been limited by the lack of a reliable positive marker for hepatocellular differentiation. Arginase-1 is a marker for HCC r...

Descripción completa

Detalles Bibliográficos
Autores principales: Radwan, Nehal A, Ahmed, Naglaa S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500209/
https://www.ncbi.nlm.nih.gov/pubmed/23111165
http://dx.doi.org/10.1186/1746-1596-7-149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500209/
https://www.ncbi.nlm.nih.gov/pubmed/23111165
http://dx.doi.org/10.1186/1746-1596-7-149

Ejemplares similares